StockTipsArenaBeta

BUY Divi's Laboratories Limited — Arpit Beriwal, Motilal Oswal

BUYDivi's Laboratories Limited

byArpit Beriwal, Motilal OswalHorizon: NA (inferred Swing (≤2wk))20 Aug 2026via ET Now

Entry₹8,600Inferred
Target₹9,000
Total upside +4.65% (call closed)
Stop lossNot given
Exit₹9,00026 Aug 2026, 1:00 pm
Target hit+4.65%0.00%upside left
Follow Arpit Beriwal for new calls(22% target hit, 58 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 6 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 26 Aug 2026
3 supporting2 neutral1 opposing
Supports the BUY call (3)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·26 Aug · today

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·19 Aug · 6d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·18 Aug · 1w ago

Neutral / worth noting (2)

Nifty 24,500 पर फिसला, Divi's, MCX और Eternal पर रखें नज़र!

NewsGoogle News·12 Aug · 2w ago

(opens in new tab)

Divi’s Laboratories Posts Q1 FY27 Earnings Call Transcript for Investors

NewsGoogle News·6 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

Indian Pharma Stocks Face Volatility After US Tariff Proposal

NewsGoogle News·14 Aug · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.